Questcor Pharmaceuticals (NASDAQ:QCOR)
CAPS Rating:
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
Growing the love for investing
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I read the questions asked by StreetSweeper's "editor" (lambaster) and Questcor's responses and I see nothing to indicate that the company is engaged in any unethical or illegal activities. Yet another attempt to provide "news" so the StreetSweeper folks can profit from shorting the stock.Read for yourself:http://finance.yahoo.com/news/Questcor-Pharmaceuticals-prnews-3875109327.html?x=0
Thank you for the link. Very enlightening and just what I’ve been looking for. Without the information contained, I had my suspicions about the integrity of Mine Sweeper’s intent. Having read Questcor’s transcription, my inner sense tells me that there is no substance to this charade and Mine Sweeper may be liable for slander or some such thing for damaging Questcor’s reputation and market price. The assertion that their two part story will be forthcoming seems overdue at best. [Full disclosure, I do own QCOR stock.]